ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv policy politics genetics genomics

Toward a “Clickable Plant”
Jane Salodof Macneil | Feb 15, 2004 | 9 min read
By conscious design, plant genomics initiatives have devoted initial resources to new technology development. Part of that money went to developing functional genomics approaches, and part to new sequencing technologies.
Will Genomics Spoil Gene Ownership?
Douglas Steinberg | Sep 3, 2000 | 8 min read
Consider a scenario for the year 2002: Using commercially available software, bioprospector "Craig Collins" spends a day scavenging the Human Genome Project (HGP) database for the alternatively spliced genes prized by Wall Street. He enters the sequences of several candidate genes into a software package that prints out the likely functions of their protein products. One protein looks like it could be pharmaceutical paydirt, so he isolates the corresponding cDNA, inserts it into a vector, then
Race and the Clinic: Good Science?
Ricki Lewis | Feb 17, 2002 | 8 min read
Humans have long embraced the idea of grouping and naming people who have distinct, genetically determined physical characteristics, like almond-shaped eyes or different skin color. It made sense, from a social standpoint (think safety, politics, and business) to align one's self with kin. However, studying race from a biological point of view, in the hopes of learning about specific diseases or developing new drugs, is a different matter altogether. "Race is generally not a useful consideration
Letters
The Scientist Staff | Sep 1, 2006 | 3 min read
A Nasty Mother The reverence for nature that Richard Gallagher1 and Lee Silver2 attribute to many scientists and nonscientists isn?t necessarily related to a view that mother nature is "benevolent," "kind," or "caring." An ecosystem can be both "in harmony" and still be deadly to individuals (even humans) and species. Many of us are very nervous about genetic engineering and other issues within bioethics because we humans just aren?t smart enough to take those functions away from
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
News in a nutshell
Bob Grant | May 16, 2010 | 3 min read
NIH grants $1B in recovery cashCoffers at the National Institutes of Health are officially $1 billion lighter after awarding recovery grants for construction, renovation, and repair projects at research institutions across the country, the agency linkurl:announced;http://www.hhs.gov/news/press/2010pres/05/20100514a.html Friday (14th May). The NIH's National Center for Research Resources (NCRR) has doled out 146 such grants to facilities in 44 states, the District of Columbia, and Puerto Rico. On
Ho, Varmus Address Serious Issues at Commencements
Eugene Russo | Jul 5, 1998 | 7 min read
Commencement ceremonies this spring at many colleges and universities across the country honored not only graduating students, but scientists hailing from a variety of fields. In recognition of their achievements, dozens of scientists received honorary degrees; some also offered words of advice to graduates. The speeches included the usual all-important cliches: Strive to be your best. Take risks. Seize opportunities. Retain your individuality. Learn for the sake of learning. However, several s
The Long Journey Home
Stephen Pincock | Jun 1, 2006 | 10+ min read
Is African Science - Long Plagued by a Lack of Equipment and Resources - Poised for a Comeback?
Vaccines: Victims of Their Own Success?
Ricki Lewis | Jul 18, 2004 | 10+ min read
Perhaps in no area is the divide between the developed and developing worlds as striking as it is for vaccines: While healthcare consumers in economically advantaged nations worry about risk, in developing nations compelling need forces a focus on potential benefit. "People in the United States want a quick solution, not prevention, so they prefer drugs to vaccines. Elsewhere, people are afraid of drugs and side effects, and prefer vaccines," says Shan Lu, a primary-care physician who has worked
AIDS Pandemic Provokes Alarming Reassessments Of Infectious Disease
Joshua Lederberg | Jul 11, 1993 | 5 min read
In 1900, infectious disease was the leading cause of mortality in the United States, accounting for at least 37 percent of deaths. By 1950, this had been mitigated to 6.8 percent and, by 1989, to 2.8 percent, with corresponding improvements in life expectancy. These numbers, of course, must be taken with a grain of salt, given the eventual preemptive role of infection in chronic illness, and many disorders whose infectious etiology is still to be recognized. Further, the relative importance

Run a Search

ADVERTISEMENT